Medicine
Vyscoxa 10 mg/mL oral suspension
Vyscoxa 10 mg/mL oral suspension is a prescription medicine containing Celecoxib for oral use, marketed by Carwin Pharmaceutical Associates, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to…
Key facts
- Active ingredient (INN)
- Celecoxib
- Brand
- Vyscoxa
- Strength
- 10 mg/mL
- Dosage form
- Oral suspension
- Route
- Oral
- Packs
- 473 mL
- Marketing authorisation holder
- Carwin Pharmaceutical Associates
- Manufacturer
- Carwin Pharmaceutical Associates
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F). Protect from Light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01XX33 Celecoxib
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 July 2025
- Identifiers
- RxCUI 2721529, 2721535DailyMed set ID 5094d47e-f791-4190-9397-b7500143a74dNDC 15370-501Application NDA211759
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 473 mL in 1 bottle | 15370-501-16 | Carwin Pharmaceutical Associates | 31 July 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Celecoxib
Clinical summary
Celecoxib is a nonsteroidal anti-inflammatory drug indicated cELEBREX is a nonsteroidal anti-inflammatory drug indicated for osteoarthritis (OA), among other approved uses. It is available as capsules, oral liquid and oral suspension. MedsAcross supplies Celecoxib for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CelecoxibFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- CELEBREX prescribing information (Viatris Specialty) · U.S. National Library of Medicine, DailyMed
Need Vyscoxa 10 mg/mL oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.